NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer

Oncotarget

Volumn 7, Issue 36, 2016, Pages 57514-57524

  Wu, Nan ^a   Jia, Deshui ^a   Ibrahim, Ali H ^a   Bachurski, Cindy J ^b   Gronostajski, Richard M ^c   MacPherson, David ^a,d  

^a USA   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Metastasis; Mouse model; NFI; Nuclear factor I; oncogene

Indexed keywords

CELL RECEPTOR; DOXYCYCLINE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFIB; UNCLASSIFIED DRUG; NFIB PROTEIN, MOUSE; NUCLEAR FACTOR I; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AXON; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FOCAL ADHESION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC MODEL; GROWTH RATE; LIVER METASTASIS; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; MOUSE; NFIB GENE; NFIB ONCOGENE; NONHUMAN; ONCOGENE; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN INTERACTION; RB GENE; SMALL CELL LUNG CANCER; TET NFIB GENE; TRANSCRIPTION REGULATION; TRANSGENE; TUMOR SUPPRESSOR GENE; ALLELE; ANIMAL; CELL MOTION; CELL SURVIVAL; DISEASE EXACERBATION; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; SECONDARY;

ALLELES; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; NFI TRANSCRIPTION FACTORS; ONCOGENES; RETINOBLASTOMA PROTEIN; SMALL CELL LUNG CARCINOMA; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84988355089     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11583     Document Type: Article

References (28)

1. Jackman DM and Johnson BE. Small-cell lung cancer. Lancet. 2005; 366:1385-1396.
2. George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, Leenders F, Lu X, Fernandez-Cuesta L, Bosco G, Muller C, Dahmen I, Jahchan NS, Park KS, Yang D, Karnezis AN, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015; 524:47-53.
3. Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, Rivers CS, Foo CK, Bhatt D, Stinson J, Gnad F, Haverty PM, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nature genetics. 2012.
4. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ and Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell. 2003; 4:181-189.
5. Sutherland KD, Proost N, Brouns I, Adriaensen D, Song JY and Berns A. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell. 2011; 19:754-764.
6. McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K, Bhutkar A, McKenna A, Dooley A, Vernon A, Sougnez C, Malstrom S, Heimann M, Park J, Chen F, Farago AF, et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell. 2014; 156:1298-1311.
7. Kim DW, Wu N, Kim YC, Cheng PF, Basom R, Kim D, Dunn CT, Lee AY, Kim K, Lee CS, Singh A, Gazdar AF, Harris CR, Eisenman RN, Park KS and MacPherson D. Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer. Genes Dev. 2016; 30:1289-1299.
8. Huijbers IJ, Bin Ali R, Pritchard C, Cozijnsen M, Kwon MC, Proost N, Song JY, de Vries H, Badhai J, Sutherland K, Krimpenfort P, Michalak EM, Jonkers J and Berns A. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO molecular medicine. 2014; 6:212-225.
9. Cui M, Augert A, Rongione M, Conkrite K, Parazzoli S, Nikitin AY, Ingolia N and Macpherson D. PTEN is a Potent Suppressor of Small Cell Lung Cancer. Mol Cancer Res. 2014.
10. Dooley AL, Winslow MM, Chiang DY, Banerji S, Stransky N, Dayton TL, Snyder EL, Senna S, Whittaker CA, Bronson RT, Crowley D, Barretina J, Garraway L, Meyerson M and Jacks T. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & development. 2011; 25:1470-1475.
11. Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, Kinsman SL, Litwack ED, Richards LJ and Gronostajski RM. The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol. 2005; 25:685-698.
12. Grunder A, Ebel TT, Mallo M, Schwarzkopf G, Shimizu T, Sippel AE and Schrewe H. Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia. Mech Dev. 2002; 112:69-77.
13. Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, Chipumuro E, Herter-Sprie GS, Akbay EA, Altabef A, Zhang J, Shimamura T, Capelletti M, Reibel JB, Cavanaugh JD, Gao P, et al. Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor. Cancer Cell. 2014; 26:909-922.
14. Borromeo MD, Savage TK, Kollipara RK, He M, Augustyn A, Osborne JK, Girard L, Minna JD, Gazdar AF, Cobb MH and Johnson JE. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. Cell reports. 2016.
15. Chapuy B, McKeown MR, Lin CY, Monti S, Roemer MG, Qi J, Rahl PB, Sun HH, Yeda KT, Doench JG, Reichert E, Kung AL, Rodig SJ, Young RA, Shipp MA and Bradner JE. Discovery and characterization of super-enhancerassociated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013; 24:777-790.
16. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA and Young RA. Super-enhancers in the control of cell identity and disease. Cell. 2013; 155:934-947.
17. Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, Jenkins CE, Hannett NM, McMillin D, Sanda T, Sim T, Kim ND, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014; 511:616-620.
18. Chiang DY, Getz G, Jaffe DB, O'Kelly MJ, Zhao X, Carter SL, Russ C, Nusbaum C, Meyerson M and Lander ES. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods. 2009; 6:99-103.
19. Xie C and Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics. 2009; 10:80.
20. Gazdar AF, Savage TK, Johnson JE, Berns A, Sage J, Linnoila RI, MacPherson D, McFadden DG, Farago A, Jacks T, Travis WD and Brambilla E. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. Journal of thoracic oncology. 2015; 10:553-564.
21. Denny SK, Yang D, Chuang CH, Brady JJ, Lim JS, Gruner BM, Chiou SH, Schep AN, Baral J, Hamard C, Antoine M, Wislez M, Kong CS, Connolly AJ, Park KS, Sage J, et al. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility. Cell. 2016; 166:328-342.
22. Semenova EA, Kwon MC, Monkhorst K, Song JY, Bhaskaran R, Krijgsman O, Kuilman T, Peters D, Buikhuisen WA, Smit EF, Pritchard C, Cozijnsen M, van der Vliet J, Zevenhoven J, Lambooij JP, Proost N, et al. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients. Cell reports. 2016; 16:631-643.
23. Bachurski CJ, Yang GH, Currier TA, Gronostajski RM and Hong D. Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription. Mol Cell Biol. 2003; 23:9014-9024.
24. Chaudhry AZ, Vitullo AD and Gronostajski RM. Nuclear factor I (NFI) isoforms differentially activate simple versus complex NFI-responsive promoters. J Biol Chem. 1998; 273:18538-18546.
25. Gossen M and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89:5547-5551.
26. Trapnell C, Pachter L and Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25:1105-1111.
27. Robinson MD, McCarthy DJ and Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26:139-140.
28. Huang da W, Sherman BT and Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4:44-57.